weight loss drugs

News

Roche’s Genentech has agreed a deal worth up to $2.3 billion to develop and sell Hanmi Pharmaceutical’s experimental obesity drug HM17321.

Digital

What does Hims & Hers aspire to achieve as it enters into new markets? Dr Craig Primack discusses misinformation surrounding obesity and weight loss.

News

Eli Lilly is claiming another victory in a head-to-head trial comparing its weight-loss drug Zepbound to its main rival Wegovy from Novo Nordisk.

Patients

It’s been less than two years since weight loss medications Wegovy and Mounjaro were approved in the UK to treat obesity.

Market Access

Recent advancements in weight-loss interventions are transforming the healthcare landscape and presenting new M&A opportunities

Market Access

In the pharmaceutical and cosmetic sectors, innovation often stems from discovering new applications for known compounds.